ArticleBMJ open2025

Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report.

Xiaojia Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.